These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


863 related items for PubMed ID: 12093772

  • 21. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
    Watanabe H, Knollmann BC.
    J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
    [Abstract] [Full Text] [Related]

  • 22.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Napolitano C, Mazzanti A, Bloise R, Priori SG.
    ; 1993. PubMed ID: 20301466
    [Abstract] [Full Text] [Related]

  • 23. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
    Campbell MJ, Czosek RJ, Hinton RB, Miller EM.
    Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045
    [Abstract] [Full Text] [Related]

  • 24. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
    Xiong J, Liu X, Gong Y, Zhang P, Qiang S, Zhao Q, Guo R, Qian Y, Wang L, Zhu L, Wang R, Hao Z, Wen H, Zhang J, Tang K, Zang WF, Yuchi Z, Chen H, Chen SRW, Zheng W, Wang SQ, Xu YW, Liu Z.
    J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
    [Abstract] [Full Text] [Related]

  • 25. Clinical characteristics and mutational analysis of the RyR2 gene in seven Czech families with catecholaminergic polymorphic ventricular tachycardia.
    Andrsova I, Valaskova I, Kubus P, Vit P, Gaillyova R, Kadlecova J, Manouskova L, Novotny T.
    Pacing Clin Electrophysiol; 2012 Jul; 35(7):798-803. PubMed ID: 22519458
    [Abstract] [Full Text] [Related]

  • 26. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B, Bagnall RD, Lam L, Ingles J, Turner C, Haan E, Davis A, Yang PC, Clancy CE, Sy RW, Semsarian C.
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [Abstract] [Full Text] [Related]

  • 27. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations - Long-Term Prognosis After Initiation of Medical Treatment.
    Kawata H, Ohno S, Aiba T, Sakaguchi H, Miyazaki A, Sumitomo N, Kamakura T, Nakajima I, Inoue YY, Miyamoto K, Okamura H, Noda T, Kusano K, Kamakura S, Miyamoto Y, Shiraishi I, Horie M, Shimizu W.
    Circ J; 2016 Aug 25; 80(9):1907-15. PubMed ID: 27452199
    [Abstract] [Full Text] [Related]

  • 28. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N, Ruan Y, Priori SG.
    Prog Cardiovasc Dis; 2008 Aug 25; 51(1):23-30. PubMed ID: 18634915
    [Abstract] [Full Text] [Related]

  • 29. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ, Arya P, Will M, Haglund CM, Farley AL, Makielski JC, Ackerman MJ.
    Heart Rhythm; 2006 Jul 25; 3(7):800-5. PubMed ID: 16818210
    [Abstract] [Full Text] [Related]

  • 30. A novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia.
    Roston TM, Guo W, Krahn AD, Wang R, Van Petegem F, Sanatani S, Chen SR, Lehman A.
    J Electrocardiol; 2017 Jul 25; 50(2):227-233. PubMed ID: 27646203
    [Abstract] [Full Text] [Related]

  • 31. BASIC AND CLINICAL INSIGHTS IN CATECHOLAMINERGIC (FAMILIAL) POLYMORPHIC VENTRICULAR TACHYCARDIA.
    Márquez MF, Totomoch-Serra A, Rueda A, Avelino-Cruz JE, Gallegos-Cortez A.
    Rev Invest Clin; 2019 Jul 25; 71(4):226-236. PubMed ID: 31448784
    [Abstract] [Full Text] [Related]

  • 32. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H.
    Am J Cardiol; 2005 Mar 01; 95(5):700-2. PubMed ID: 15721128
    [Abstract] [Full Text] [Related]

  • 33. [Catecholaminergic polymorphic ventricular tachycardia (CPVT): an insidious disease that can often lead to sudden cardiac death in young people].
    Marschall C, Schön U, Diebold I.
    MMW Fortschr Med; 2024 Aug 01; 166(Suppl 5):9-15. PubMed ID: 39112835
    [Abstract] [Full Text] [Related]

  • 34. Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four-generation Canadian family.
    Tung M, Van Petegem F, Lauson S, Collier A, Hodgkinson K, Fernandez B, Connors S, Leather R, Sanatani S, Arbour L.
    Mol Genet Genomic Med; 2020 Apr 01; 8(4):e1151. PubMed ID: 31994352
    [Abstract] [Full Text] [Related]

  • 35. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
    Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ.
    J Am Coll Cardiol; 2009 Nov 24; 54(22):2065-74. PubMed ID: 19926015
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation].
    Liu X, Li JX, Hu JZ, Shen Y, Wan R, Xiong QM, Zhou QQ, Xie JY, Jin JJ, Yan X, Yu JH, Hong K.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan 25; 45(1):39-43. PubMed ID: 28100344
    [Abstract] [Full Text] [Related]

  • 38. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
    Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H.
    Cardiovasc Res; 2005 Aug 15; 67(3):379-87. PubMed ID: 15913575
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 44.